ASKA Pharmaceutical Holdings (4886) · InitiativeRestated
A Reliability-Oriented Corporate Culture and Rigorous Compliance
First written in FY2022. 1 of 3 entries say "Advanced", first in FY2023. Latest entry: FY2024.
3entries
3years
0from disclosures
How it moved
Same theme, other companies
Establishment of a Corporate Ethics and Compliance FrameworkA theme 142 companies write about · 2 as a headwind · 141 as a tailwind
103 other companies' latest entry also says "Restated".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 142 companies compared. The sentences above are computed from all 142.Full recordFilings, disclosures and news, newest first
- FY2024RestatedAnnual report
「また、昨今の製薬業界における製造工程での不祥事を踏まえ、当社グループでは、信頼性保証部門及び製造部門が連携し、ＧＭＰ遵守の徹底を図っています。」
信頼性保証部門と製造部門が連携してGMP遵守を徹底する対応を再掲している。 - FY2023AdvancedAnnual report
「信頼性保証部門及び製造部門が連携し、ＧＭＰ遵守の徹底を図っています。」
信頼性重視とコンプライアンス徹底について、製薬業界の製造工程不祥事を踏まえたGMP遵守という具体的対応を記載している。 - FY2022First statedAnnual report
「By fostering a corporate culture that emphasizes reliability and ensuring rigorous compliance, we will fulfill our responsibilities as a life sciences company.」
Fostering a reliability-oriented corporate culture and ensuring rigorous compliance are identified as specific initiatives under the growth strategy.